This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reiber, G E
Right arrow Articles by LeMaster, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reiber, G E
Right arrow Articles by LeMaster, J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Facebook   Add to Technorati   Add to Twitter  
What's this?
The Journal of Bone and Joint Surgery (American) 84:2107 (2002)
© 2002 The Journal of Bone and Joint Surgery, Inc.

Evidence-Based Orthopaedics

Two Types of Therapeutic Shoes Were No Better Than Usual Footwear for Preventing Foot Reulceration

G E Reiber, D G Smith, C Wallace, K Sullivan, S Hayes, C Vath, M L Maciejewski, O Yu, P J Heagerty and J LeMaster

Effect of therapeutic footwear on foot reulceration in patients with diabetes:a randomized controlled trial. JAMA. 2002 May 15;287:2552-8.

Sources of funding: Department of Veterans Affairs, National Institute of Diabetes and Digestive and Kidney Diseases, and Centers for Disease Control and Prevention.

For correspondence: Dr. G.E. Reiber, VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98108, USA. E-mail address: greiber@u.washington.edu

The first 20% of the full text of this article appears below.

Question: In patients with diabetes and previous foot ulcers, how effective are 2 types of therapeutic shoes compared with usual footwear in preventing foot reulceration?

Design: Randomized (allocation concealed), blinded (outcome assessors for final ulcer classification), controlled trial with a 2-year follow-up.

Setting: 2 health-care organizations in Washington State, USA.

Patients: 400 patients (mean age, 62 years [range, 45 to 84 years]; 77% men) who had diabetes, a history of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Facebook Facebook   Add to Technorati Technorati   Add to Twitter Twitter    What's this?